Harumi Takahashi
Department of Pharmacotherapy
Meiji Pharmaceutical University
Kiyose
Tokyo
Japan
Name/email consistency: high
- Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Takahashi, H., Wilkinson, G.R., Nutescu, E.A., Morita, T., Ritchie, M.D., Scordo, M.G., Pengo, V., Barban, M., Padrini, R., Ieiri, I., Otsubo, K., Kashima, T., Kimura, S., Kijima, S., Echizen, H. Pharmacogenet. Genomics (2006)
- CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences. Takahashi, H., Wilkinson, G.R., Padrini, R., Echizen, H. Clin. Pharmacol. Ther. (2004)
- Pharmacogenetics of warfarin elimination and its clinical implications. Takahashi, H., Echizen, H. Clin. Pharmacokinet (2001)









